HomeProductsBioactive CompoundsEpigeneticsPARPAtamparib
Chemical structure of CAS 2381037-82-5

Atamparib

CAS No.2381037-82-5
MDL No.MFCD32701939
MFC20H23F6N7O3
MW523.40
InChI KeyUQZCQKXJAXKZQH-LBPRGKRZSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2381037-82-5
Product NameAtamparib

Associated Conditions

neoplasm·non-small cell lung carcinoma
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Discovery of Highly Selective PARP7 Inhibitors with a Novel Scaffold for Cancer Immunotherapy.

Journal of medicinal chemistry • Vol. 67, Issue 3 • 2024
PMID: 38059836DOI: 10.1021/acs.jmedchem.3c01764

Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.

Journal of medicinal chemistry • Vol. 65, Issue 11 • 2022
PMID: 35608571PMC: PMC9189837DOI: 10.1021/acs.jmedchem.2c00281

Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15.

European journal of medicinal chemistry • Vol. 237 • 2022
PMID: 35500474DOI: 10.1016/j.ejmech.2022.114362

Clinical trials of oxprenolol in anxiety.

Scottish medical journal • Vol. 20, Issue 6 • 1975
PMID: 4887DOI: 10.1177/003693307502000607

Documentation